Cesarean Wound Disruption Clinical Trial
Official title:
The Influence of Endometrial Suturing During Cesarean Section on the Risk to Develop Uterine Scar Defect: A Randomized Control Study
NCT number | NCT03851003 |
Other study ID # | 5822-18-SMC |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 1, 2019 |
Est. completion date | July 1, 2022 |
Verified date | September 2023 |
Source | Sheba Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Caesarean section (CS) is the commonest major operation performed on women worldwide with progressively rising incidence. Consequently, long-term adverse sequelae due to uterine scar defect have been increasing. Given the association between uterine scar defect and gynecological symptoms, obstetric complications and potentially with subfertility, it is important to elucidate the etiology in order to develop preventive strategies. Surgical technique of uterine incision closure seems to be the most important determinant of defect formation. The aim of this prospective randomized study is to evaluate specifically the influence of inclusion versus exclusion of the endometrium during suturing the uterine incision on the risk to develop uterine scar defect.
Status | Completed |
Enrollment | 130 |
Est. completion date | July 1, 2022 |
Est. primary completion date | July 1, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 42 Years |
Eligibility | Inclusion Criteria: - Term pregnancy (=37 weeks of gestation) - Elective CS Exclusion Criteria: - Uterine scar - Thrombophilia - Dysmorphic uterus - Connective tissue disorder |
Country | Name | City | State |
---|---|---|---|
Israel | Dr. Aya Mohr-Sasson | Ramat-Gan |
Lead Sponsor | Collaborator |
---|---|
Sheba Medical Center |
Israel,
Mathai M, Hofmeyr GJ, Mathai NE. Abdominal surgical incisions for caesarean section. Cochrane Database Syst Rev. 2013 May 31;(5):CD004453. doi: 10.1002/14651858.CD004453.pub3. — View Citation
Sholapurkar SL. Etiology of Cesarean Uterine Scar Defect (Niche): Detailed Critical Analysis of Hypotheses and Prevention Strategies and Peritoneal Closure Debate. J Clin Med Res. 2018 Mar;10(3):166-173. doi: 10.14740/jocmr3271w. Epub 2018 Jan 26. — View Citation
Tulandi T, Cohen A. Emerging Manifestations of Cesarean Scar Defect in Reproductive-aged Women. J Minim Invasive Gynecol. 2016 Sep-Oct;23(6):893-902. doi: 10.1016/j.jmig.2016.06.020. Epub 2016 Jul 5. — View Citation
van der Voet LF, Bij de Vaate AM, Veersema S, Brolmann HA, Huirne JA. Long-term complications of caesarean section. The niche in the scar: a prospective cohort study on niche prevalence and its relation to abnormal uterine bleeding. BJOG. 2014 Jan;121(2): — View Citation
Vervoort AJ, Uittenbogaard LB, Hehenkamp WJ, Brolmann HA, Mol BW, Huirne JA. Why do niches develop in Caesarean uterine scars? Hypotheses on the aetiology of niche development. Hum Reprod. 2015 Dec;30(12):2695-702. doi: 10.1093/humrep/dev240. Epub 2015 Se — View Citation
Wang CB, Chiu WW, Lee CY, Sun YL, Lin YH, Tseng CJ. Cesarean scar defect: correlation between Cesarean section number, defect size, clinical symptoms and uterine position. Ultrasound Obstet Gynecol. 2009 Jul;34(1):85-9. doi: 10.1002/uog.6405. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of participants with uterine scar defect six month post cesarean section | Uterine scar defect with residual myometrium thickness of less then 2.5 mm | Until six month post cesarean section, and through study completion, an average of 1 year | |
Secondary | Spotting | The rate of spotting complains since operation reported by the women | Through study completion, an average of 1 year | |
Secondary | Abdominal pain | The rate of abdominal pain since operation reported by the women and estimated by "The Visual Analogue Scale" (VAS) for the estimation of pain. In this scale, women will be asked to mark the pain that they are experiencing on a 10cm-long horizontal line labeled "no pain" on the far left and "worst pain ever" on the far right. Pain intensity is determined by the length of the line as measured from the left-hand side to the point marked. The following cut points on the pain VAS will be use: no pain (0-0.4 cm), mild pain (0.5-4.4 cm), moderate pain (4.5-7.4 cm), and severe pain (7.5-10 cm). | Through study completion, an average of 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04359472 -
The Collection and Application of Autologous Amniotic Fluid at Cesarean Delivery Closure.
|
N/A | |
Completed |
NCT03968783 -
The Effect of Suturing Material on Scar Healing
|
N/A | |
Not yet recruiting |
NCT03111706 -
2D and 3D Ultrasound Assessment of Cesarean Section Scars
|
N/A | |
Completed |
NCT03223233 -
Predicting the Severity of Post-cesarean Wound Infections Using Serum Procalcitonin Levels
|
N/A | |
Completed |
NCT04587960 -
Delayed Primary Closure of Skin in Emergency Caesarean Section
|
N/A | |
Recruiting |
NCT03966001 -
Cesarean Scar Defect Formation After First Cesarean Section.
|
||
Recruiting |
NCT05164224 -
Serum Procalcitonin and Post-cesarean Wound Infection
|
||
Completed |
NCT03414762 -
PICO Negative Pressure Wound Therapy in Obese Women Undergoing Elective Cesarean Delivery.
|
Phase 3 |